Burlingame, CA, United States of America

Brandon Heath Brown

USPTO Granted Patents = 13 

 

 

Average Co-Inventor Count = 3.7

ph-index = 5

Forward Citations = 56(Granted Patents)


Location History:

  • Newark, CA (US) (2015)
  • Burlingame, CA (US) (2016 - 2021)
  • Niwot, CO (US) (2022)

Company Filing History:


Years Active: 2015-2025

Loading Chart...
Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: Inventor Spotlight on Brandon Heath Brown

Introduction

Brandon Heath Brown is an accomplished inventor based in Burlingame, California. With a total of 12 patents to his name, Brown has significantly contributed to advancements in the field of biotechnology, particularly in the treatment of various diseases.

Latest Patents

Among his notable inventions, Brown's recent patents include innovative processes for preparing ASK1 inhibitors. These compounds are crucial for inhibiting apoptosis signal-regulating kinase, which plays a role in several diseases, including kidney disease, diabetic nephropathy, and kidney fibrosis. Additionally, he has developed solid forms of a toll-like receptor modulator, featuring crystalline forms, solvates, and hydrates of a specific chemical compound, along with methods for their preparation.

Career Highlights

Brandon Heath Brown is currently affiliated with Gilead Sciences, Inc., a leading biopharmaceutical company known for its focus on innovative therapeutics. His role at Gilead has positioned him at the forefront of cutting-edge research and development in medicinal chemistry.

Collaborations

Brown collaborates regularly with fellow experts in his field, including Richard Hung Chiu Yu and Troy Evan Reynolds. These partnerships enhance the innovative process and contribute to the success of their research endeavors.

Conclusion

Brandon Heath Brown exemplifies the spirit of innovation, leveraging his expertise in the biotechnology sector to create impactful inventions. His work not only pushes the boundaries of science but also offers hope for the treatment of complex diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…